Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Ocular manifestations of diabetes and hypertension
Essential points for quick revision.
2 min synopsisUK scopeSources checked 7 Sept 2026Clinical review pending
!
Retinal signs can identify a systemic emergency
Severe hypertension with retinal haemorrhage or optic-disc swelling can indicate accelerated hypertension. New visual loss in a person with diabetes may instead reflect an acute retinal or neurological event.
Action: Arrange same-day specialist assessment when clinic systolic pressure is at least 180 mmHg or diastolic pressure is at least 120 mmHg, with retinal haemorrhage or papilloedema, as specified by NICE. Use emergency eye or stroke pathways for sudden visual loss, a new field defect or focal neurological symptoms.
Synopsis
Recognise how diabetes and hypertension affect the eye, connect retinal findings with systemic risk, and coordinate screening, emergency assessment and ongoing treatment.
Diabetic retinal damage can be clinically important before the person notices any visual change.
Microvascular leakage and capillary closure produce different retinal findings and may coexist in the same eye.
Hypertensive and diabetic changes overlap; examination findings must be interpreted alongside measured blood pressure and systemic assessment.
Key red flags
Clinic systolic pressure at least 180 mmHg or diastolic pressure at least 120 mmHg, with retinal haemorrhage or papilloedema, requires same-day specialist assessment.
Investigation priorities
01
Visual acuity and appropriate retinal examinationFirst step
Identify present visual impairment and clinically important retinal pathology.
Management branches
Acute retinal and systemic riskAct on the dangerous combination
Severe hypertension accompanies retinal injury or new visual symptoms suggest an acute event.
Arrange same-day specialist care for the NICE severe-pressure and retinal-sign combination, including assessment for injury outside the eye.
For sudden visual loss or a new field shadow, use the appropriate emergency retinal or neurological pathway without waiting for screening.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.